Case number 1:22-cv-00724
Galderma Laboratories, L.P. et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 23, 2023 | 44 | SO ORDERED, regarding D.I. 43 Stipulation filed by TCD Royalty Sub LP, Galderma Laboratories, L.P. Signed by Judge Stephanos Bibas on 6/23/2023. (apk) (Entered: 06/23/2023) (0) |
| Jun 23, 2023 | 43 | STIPULATION Regarding Claim Construction [Corrected] re 42 Stipulation by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 06/23/2023) (3) |
| Jun 16, 2023 | 42 | STIPULATION Regarding Claim Construction by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 06/16/2023) (3) |
| Jun 12, 2023 | 41 | SO ORDERED, regarding D.I. 40 STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates (Claim Construction Opening Brief due by 7/7/2023., Claim Construction Answering Brief due by 7/28/2023., Claim Construction Reply Brief due by 8/11/2023., Claim Construction Sur-Reply Brief due by 8/21/2023., Joint Claim Construction Brief due by 8/24/2023.) Signed by Judge Stephanos Bibas on 6/12/2023. (apk) (Entered: 06/12/2023) (0) |
| Jun 9, 2023 | 40 | STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 06/09/2023) (2) |
| Jun 6, 2023 | 39 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms for Construction filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 06/06/2023) (3) |
| May 26, 2023 | 38 | NOTICE OF SERVICE of Apotex's Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-121) filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) (Entered: 05/26/2023) (2) |
| May 19, 2023 | 37 | NOTICE OF SERVICE of INITIAL INVALIDITY CONTENTIONS filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 05/19/2023) (2) |
| May 12, 2023 | 36 | SO ORDERED, regarding D.I. 35 STIPULATION TO EXTEND TIME for Defendants Apotex Inc. and Apotex Corp. to serve Initial Invalidity Contentions to May 19, 2023 (Notice of Compliance deadline set for 5/19/2023.) Signed by Judge Stephanos Bibas on 5/12/2023. (apk) (Entered: 05/12/2023) (0) |
| May 11, 2023 | 35 | STIPULATION TO EXTEND TIME for Defendants Apotex Inc. and Apotex Corp. to serve Initial Invalidity Contentions to May 19, 2023 - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 05/11/2023) (2) |
| Apr 28, 2023 | 34 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Chart filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 04/28/2023) (3) |
| Apr 26, 2023 | 33 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 04/26/2023) (3) |
| Mar 27, 2023 | 32 | NOTICE OF SERVICE of Apotex's Production of Core Technical Documents filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 03/27/2023) (2) |
| Mar 27, 2023 | 31 | SO ORDERED, regarding D.I. 28 Proposed Order filed by TCD Royalty Sub LP, Galderma Laboratories, L.P., and D.I. 27 Proposed Order filed by TCD Royalty Sub LP, Galderma Laboratories, L.P. Signed by Judge Stephanos Bibas on 03/27/2023. (apk) (Entered: 03/27/2023) (0) |
| Mar 24, 2023 | 30 | NOTICE OF SERVICE of Apotex's Paragraph 3 Disclosures filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 03/24/2023) (2) |
| Mar 24, 2023 | 29 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/24/2023) (3) |
| Mar 24, 2023 | 28 | PROPOSED ORDER -- [Proposed] Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI") -- by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 03/24/2023) (10) |
| Mar 24, 2023 | 27 | PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 03/24/2023) (19) |
| Mar 17, 2023 | 26 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents and (2) Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/17/2023) (3) |
| Mar 17, 2023 | 25 | NOTICE OF SERVICE of Apotex's Rule 26(a)(1) Initial Disclosures filed by Apotex Corp., Apotex Inc..(Hitch, Cortlan) (Entered: 03/17/2023) (2) |
| Mar 13, 2023 | 24 | SCHEDULING ORDER: Joinder of Parties due by 9/1/2023. Amended Pleadings due by 9/1/2023. Discovery due by 12/1/2023. Opening Expert Reports due by 1/19/2024. Rebuttal Expert Reports due by 2/23/2024. Expert Discovery due by 3/29/2023. Status Report due by 9/1/2023. Claim Construction Opening Brief due by 6/30/2023. Claim Construction Answering Brief due by 7/21/2023. Claim Construction Reply Brief due by 8/4/2023. Claim Construction Surreply Brief due by 8/14/2023. Joint Claim Construction Brief due by 8/17/2023. Proposed Pretrial Order due by 5/17/2024.(See Order for further details) Signed by Judge Stephanos Bibas on 03/13/2023. (smg) (Entered: 03/13/2023) (13) |
| Mar 10, 2023 | 23 | Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- (with disputed provisions) re 22 Oral Order by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 03/10/2023) (16) |
| Mar 1, 2023 | 22 | ORAL ORDER, I ORDER the parties to submit a proposed scheduling order by March 10, 2023, at 5 p.m. eastern time. Ordered by Judge Stephanos Bibas on 3/1/2023. (twk) (Entered: 03/01/2023) (0) |
| Feb 28, 2023 | 21 | Joint Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Joint Status Report - re 20 Oral Order,. (Tigan, Jeremy) (Entered: 02/28/2023) (2) |
| Feb 21, 2023 | 20 | ORAL ORDER: I ORDER the parties to confer and submit a joint status report, not to exceed three single-spaced pages, by February 28, 2023, at 5 p.m. eastern time. The report shall discuss Galderma Laboratories L.P. v. Lupin Inc., 1:21-cv-01710-SB, as well as the need for a scheduling conference and scheduling order. Ordered by Judge Stephanos Bibas on 02/21/2023. Associated Cases: 1:22-cv-00724-SB, 1:22-cv-01166-SB, 1:22-cv-01312-SB(smg) (Entered: 02/21/2023) (0) |
| Feb 8, 2023 | 19 | NOTICE of Change of Firm Affiliation by Galderma Laboratories, L.P., TCD Royalty Sub LP (Tigan, Jeremy) (Entered: 02/08/2023) (2) |
| Feb 3, 2023 | 18 | NOTICE requesting Clerk to remove Evan D. Diamond, Vanessa Y. Yen, and the law firm of King & Spalding LLP as co-counsel.. (Tigan, Jeremy) (Entered: 02/03/2023) (2) |
| Jan 5, 2023 | 17 | NOTICE of Change of Firm Affiliation by Galderma Laboratories, L.P., TCD Royalty Sub LP (Blumenfeld, Jack) (Entered: 01/05/2023) (3) |
| Jul 14, 2022 | 16 | Answer to Counterclaim (7) Docket Text: ANSWER to [13] Answer to Complaint, Counterclaim by Galderma Laboratories, L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Jun 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Lance A. Soderstrom, Deepro R. Mukerjee, and Joseph M. Janusz for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 23, 2022 | 15 | Order on Motion to Appear Pro Hac Vice (5) Docket Text: ORDER granting [9] MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz, Attorney Deepro R. Mukerjee, and Attorney Lance A. Soderstrom. Signed by Judge Stephanos Bibas on 6/23/2022. (srs) |
| Jun 23, 2022 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc.; Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) |
| Jun 23, 2022 | 13 | Answer to Complaint (12) Docket Text: ANSWER to [1] Complaint , COUNTERCLAIM against Apotex Corp., Apotex Inc. by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) |
| Jun 23, 2022 | 12 | Order on Motion to Appear Pro Hac Vice (7) Docket Text: ORDER granting [11] MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran. Signed by Judge Stephanos Bibas on 6/23/2022. (nmg) |
| Jun 23, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gerald J. Flattmann, Jr, Evan D. Diamond, Andrew J. Cochran, and Vanessa Y. Yen for Galderma Laboratories, L.P. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 17, 2022 | 11 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Jun 9, 2022 | 10 | Order (1) Docket Text: ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 6/9/2022. (rjb) |
| Jun 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) |
| Jun 6, 2022 | 9 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Joseph M. Janusz, Attorney Deepro R. Mukerjee, and Attorney Lance A. Soderstrom - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) |
| Jun 2, 2022 | 1 | Complaint* (1) |
| Jun 2, 2022 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by TCD Royalty Sub LP, Galderma Laboratories, L.P.. Apotex Corp. served on 6/2/2022, answer due 6/23/2022. (Tigan, Jeremy) |
| Jun 2, 2022 | 7 | Summons Issued (2) Docket Text: Summons Issued as to Apotex Corp. on 6/2/2022. (twk) |
| Jun 2, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued as to Apotex Inc. on 6/2/2022. (twk) |
| Jun 2, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma Services Inc. for Galderma Laboratories, L.P.; Corporate Parents Drug Royalty III LP 2, DRI Healthcare Trust for TCD Royalty Sub LP - filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (twk) |
| Jun 2, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (twk) |
| Jun 2, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about April 20, 2022. Date of Expiration of Patent: December 24, 2025 (U.S. Patent No. 8,206,740), December 19, 2027 (U.S. Patent No. 7,749,532). Thirty Month Stay Deadline: 10/20/2024. (twk) |
| Jun 2, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Jun 2, 2022 | 1 | Civil Cover Sheet (1) |
| Jun 2, 2022 | 1 | Exhibit A-B (37) |
| Jun 2, 2022 | 1 | Main Document (9) Docket Text: COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 402, receipt number ADEDC-3887209.) - filed by TCD Royalty Sub LP, Galderma Laboratories, L.P.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(twk) |
